Carol A. Kemp

584 total citations
10 papers, 488 citations indexed

About

Carol A. Kemp is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Carol A. Kemp has authored 10 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Carol A. Kemp's work include Pharmacogenetics and Drug Metabolism (10 papers), Computational Drug Discovery Methods (4 papers) and Analytical Chemistry and Chromatography (3 papers). Carol A. Kemp is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Computational Drug Discovery Methods (4 papers) and Analytical Chemistry and Chromatography (3 papers). Carol A. Kemp collaborates with scholars based in United Kingdom and Bulgaria. Carol A. Kemp's co-authors include Michael J. Sutcliffe, Gordon C. K. Roberts, Mark J. I. Paine, C. Roland Wolf, Jean‐Didier Maréchal, Jack U. Flanagan, Lesley A. McLaughlin, Stewart B. Kirton, C. J. Ward and Richard J. Ward and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical Journal.

In The Last Decade

Carol A. Kemp

10 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol A. Kemp United Kingdom 10 399 179 169 155 132 10 488
Margit Spatzenegger Austria 8 385 1.0× 117 0.7× 185 1.1× 71 0.5× 157 1.2× 13 562
Christine Yang United States 4 303 0.8× 172 1.0× 138 0.8× 86 0.6× 115 0.9× 5 418
Sean C. Gay United States 10 250 0.6× 119 0.7× 138 0.8× 63 0.4× 106 0.8× 13 363
Cristina Marques‐Soares France 7 372 0.9× 183 1.0× 151 0.9× 94 0.6× 153 1.2× 8 470
Lovisa Afzelius Sweden 13 488 1.2× 360 2.0× 261 1.5× 173 1.1× 217 1.6× 21 763
Michael P. Pritchard United Kingdom 14 535 1.3× 89 0.5× 346 2.0× 79 0.5× 250 1.9× 18 812
Matthew A. Cerny United States 14 349 0.9× 99 0.6× 170 1.0× 61 0.4× 218 1.7× 25 655
Zhoupeng Zhang United States 17 283 0.7× 107 0.6× 249 1.5× 81 0.5× 96 0.7× 26 634
Tammy L. Domanski United States 16 913 2.3× 188 1.1× 282 1.7× 156 1.0× 504 3.8× 18 1.1k
Vincent Peterkin United States 7 563 1.4× 131 0.7× 252 1.5× 71 0.5× 315 2.4× 10 818

Countries citing papers authored by Carol A. Kemp

Since Specialization
Citations

This map shows the geographic impact of Carol A. Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol A. Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol A. Kemp more than expected).

Fields of papers citing papers by Carol A. Kemp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol A. Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol A. Kemp. The network helps show where Carol A. Kemp may publish in the future.

Co-authorship network of co-authors of Carol A. Kemp

This figure shows the co-authorship network connecting the top 25 collaborators of Carol A. Kemp. A scholar is included among the top collaborators of Carol A. Kemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol A. Kemp. Carol A. Kemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Maréchal, Jean‐Didier, Carol A. Kemp, Gordon C. K. Roberts, et al.. (2007). Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6‐drug interactions. British Journal of Pharmacology. 153(S1). S82–9. 44 indexed citations
2.
Paine, Mark J. I., Jean‐Didier Maréchal, Carol A. Kemp, et al.. (2006). IN SILICO PREDICTION OF DRUG BINDING TO CYP2D6: IDENTIFICATION OF A NEW METABOLITE OF METOCLOPRAMIDE. Drug Metabolism and Disposition. 34(8). 1386–1392. 28 indexed citations
3.
McLaughlin, Lesley A., Mark J. I. Paine, Carol A. Kemp, et al.. (2005). Why Is Quinidine an Inhibitor of Cytochrome P450 2D6?. Journal of Biological Chemistry. 280(46). 38617–38624. 61 indexed citations
4.
Kemp, Carol A., Jack U. Flanagan, Jean‐Didier Maréchal, et al.. (2004). Validation of Model of Cytochrome P450 2D6:  An in Silico Tool for Predicting Metabolism and Inhibition. Journal of Medicinal Chemistry. 47(22). 5340–5346. 60 indexed citations
5.
Kemp, Carol A., Jean‐Didier Maréchal, & Michael J. Sutcliffe. (2004). Progress in cytochrome P450 active site modeling. Archives of Biochemistry and Biophysics. 433(2). 361–368. 20 indexed citations
6.
Flanagan, Jack U., Jean‐Didier Maréchal, Richard J. Ward, et al.. (2004). Phe120 contributes to the regiospecificity of cytochrome P450 2D6: mutation leads to the formation of a novel dextromethorphan metabolite. Biochemical Journal. 380(2). 353–360. 62 indexed citations
7.
Lawson, Rachel J., David Leys, Michael J. Sutcliffe, et al.. (2004). Thermodynamic and Biophysical Characterization of Cytochrome P450 BioI from Bacillus subtilis. Biochemistry. 43(39). 12410–12426. 44 indexed citations
8.
Munro, Andrew W., Kirsty J. McLean, Ashley J. Warman, et al.. (2003). Cytochromes P450: novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis. Biochemical Society Transactions. 31(3). 625–630. 24 indexed citations
9.
Paine, Mark J. I., Lesley A. McLaughlin, Jack U. Flanagan, et al.. (2003). Residues Glutamate 216 and Aspartate 301 Are Key Determinants of Substrate Specificity and Product Regioselectivity in Cytochrome P450 2D6. Journal of Biological Chemistry. 278(6). 4021–4027. 95 indexed citations
10.
Kirton, Stewart B., et al.. (2002). Impact of incorporating the 2C5 crystal structure into comparative models of cytochrome P450 2D6. Proteins Structure Function and Bioinformatics. 49(2). 216–231. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margit Spatzenegger Breakdown of academic impact, for papers by Christine Yang Breakdown of academic impact, for papers by Sean C. Gay Breakdown of academic impact, for papers by Cristina Marques‐Soares Breakdown of academic impact, for papers by Lovisa Afzelius Breakdown of academic impact, for papers by Michael P. Pritchard Breakdown of academic impact, for papers by Matthew A. Cerny Breakdown of academic impact, for papers by Zhoupeng Zhang Breakdown of academic impact, for papers by Tammy L. Domanski Breakdown of academic impact, for papers by Vincent Peterkin
Rankless by CCL
2026